| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |